Tofogliflozin is a selective sodium-glucose cotransporter-2 (SGLT2) inhibitor indicated for the treatment of type 2 diabetes mellitus, functioning by lowering blood glucose levels and supporting body weight… Read more
Tofogliflozin is a selective sodium-glucose cotransporter-2 (SGLT2) inhibitor indicated for the treatment of type 2 diabetes mellitus, functioning by lowering blood glucose levels and supporting body weight management. This category provides a comprehensive range of analytical tools necessary for rigorous pharmaceutical research and regulatory compliance, including the active pharmaceutical ingredient as a primary reference standard. Analytical chemists utilize these high-quality compounds, including identified impurities and degradation products, for precise impurity profiling and the validation of analytical methods to ensure consistent drug quality. Additionally, stable isotope labelled compounds such as Tofogliflozin-d5 serve as essential internal standards for mass spectrometry-based quantitative bioanalytical assays and pharmacokinetic studies. Laboratories rely on these materials to maintain high standards in quality control and to support the thorough characterization required throughout the drug development lifecycle.